SNY | Sanofi Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31
Revenue	43.07B	45.39B	39.17B	37.37B	37.63B	35.68B	36.20B	34.71B	34.86B	34.11B	33.31B	35.96B	35.06B	32.03B	30.75B	28.82B	29.25B	29.49B	28.49B	15.03B	8.03B	7.46B	6.49B	5.96B	5.35B
Cost of Revenue	16.57B	13.70B	12.26B	12.16B	11.98B	11.32B	11.61B	10.70B	10.92B	11.03B	10.99B	11.12B	10.90B	8.72B	7.88B	7.34B	7.58B	7.59B	7.56B	3.75B	1.43B	1.38B	1.25B	1.44B	1.49B
Gross Profit	26.50B	31.69B	26.92B	25.21B	25.65B	24.36B	24.59B	24.01B	23.94B	23.08B	22.32B	24.84B	24.16B	23.32B	22.87B	21.48B	21.67B	21.90B	20.93B	11.28B	6.61B	6.08B	5.24B	4.52B	3.86B
Operating Expenses	17.32B	19.81B	17.77B	17.32B	18.47B	17.99B	17.39B	16.48B	16.81B	16.25B	15.84B	17.05B	16.97B	15.98B	15.05B	15.58B	15.61B	15.90B	15.21B	11.59B	3.54B	3.46B	3.13B	2.94B	2.89B
Selling, General & Admin	10.59B	10.49B	9.55B	9.39B	9.88B	9.93B	10.06B	9.49B	9.38B	9.11B	8.60B	8.95B	8.54B	7.57B	7.33B	7.17B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Research & Development	6.72B	6.71B	5.69B	5.53B	6.02B	6.35B	5.47B	5.17B	5.08B	4.82B	4.77B	4.92B	4.81B	4.40B	4.58B	4.58B	4.54B	4.43B	4.04B	7.45B	1.31B	1.22B	1.03B	945.00M	N/A
Other Operating Expenses	2.00M	-370.00M	-5.00M	136.00M	327.00M	1.70B	1.86B	1.82B	2.35B	2.32B	2.46B	3.18B	3.62B	4.02B	3.14B	3.84B	11.07B	11.47B	11.17B	4.14B	2.23B	2.24B	2.10B	2.00B	2.89B
Operating Income	9.18B	10.66B	8.13B	14.11B	3.05B	12.43B	5.80B	7.53B	7.13B	6.83B	6.48B	7.79B	7.19B	7.33B	7.82B	5.90B	6.06B	6.00B	5.72B	-304.66M	3.07B	2.62B	2.11B	1.58B	971.00M
Other Expenses / Income	-2.03B	-1.23B	-1.02B	6.22B	-4.13B	-7.53B	-273.00M	-1.85B	-1.89B	-1.10B	-1.88B	-1.91B	-1.87B	-1.73B	-1.75B	-1.74B	-276.41M	-1.26B	-3.08B	-1.54B	58.76M	-109.59M	34.00M	-17.00M	N/A
Before Tax Income	7.15B	10.42B	7.80B	13.78B	2.75B	4.90B	5.53B	5.68B	5.24B	5.73B	4.60B	5.88B	5.32B	5.60B	6.07B	4.16B	5.78B	4.75B	2.64B	-1.84B	3.13B	2.51B	2.14B	1.56B	N/A
Income Tax Expenses	1.60B	2.01B	1.56B	1.81B	121.00M	481.00M	1.72B	1.33B	709.00M	1.17B	763.00M	1.13B	455.00M	1.24B	1.36B	682.00M	687.93M	800.12M	477.04M	818.09M	1.06B	747.13M	842.00M	611.00M	N/A
Net Income	5.40B	8.37B	6.22B	12.29B	2.75B	4.31B	8.43B	4.71B	4.29B	4.39B	3.72B	4.97B	5.69B	5.47B	5.26B	4.29B	5.27B	4.01B	2.26B	-3.61B	2.07B	1.76B	1.58B	985.00M	625.00M
Interest Expenses	1.09B	472.00M	403.00M	434.00M	465.00M	-399.00M	420.00M	924.00M	559.00M	605.00M	612.00M	553.00M	552.00M	467.00M	324.00M	335.00M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	2.50B	2.50B	2.50B	2.51B	2.50B	1.26B	2.51B	2.57B	2.61B	2.63B	2.65B	2.64B	2.64B	2.61B	2.61B	2.62B	2.69B	2.69B	2.67B	1.85B	1.41B	1.46B	1.46B	1.46B	1.47B
Diluted Shares Outstanding	2.51B	2.51B	2.52B	2.52B	2.51B	1.26B	2.51B	2.57B	2.61B	2.63B	2.65B	2.64B	2.64B	2.61B	2.61B	2.63B	2.71B	2.72B	2.69B	1.85B	1.41B	1.46B	1.46B	1.46B	1.47B
EBITDA	12.96B	15.54B	12.56B	11.80B	15.12B	9.36B	14.26B	10.26B	9.83B	9.94B	10.66B	11.56B	12.25B	12.30B	11.96B	11.29B	10.63B	10.92B	8.68B	-272.94M	3.52B	2.89B	2.73B	1.84B	861.00M
EBITDA Margin	30.09%	34.24%	32.07%	31.57%	40.17%	26.24%	39.39%	29.56%	28.20%	29.15%	32.01%	32.15%	34.95%	38.41%	38.91%	39.19%	36.34%	37.03%	30.46%	-1.82%	43.78%	38.72%	42.05%	30.81%	16.09%
EBIT	8.10B	10.85B	8.18B	14.54B	3.34B	4.39B	10.58B	6.96B	5.55B	6.17B	5.09B	6.65B	6.70B	7.18B	6.95B	5.31B	5.96B	4.81B	2.73B	-2.79B	3.13B	2.51B	2.43B	1.60B	625.00M
EBIT Margin	18.80%	23.90%	20.89%	38.90%	8.88%	12.30%	29.21%	20.05%	15.93%	18.08%	15.29%	18.51%	19.11%	22.40%	22.61%	18.42%	20.37%	16.30%	9.59%	-18.56%	38.94%	33.63%	37.41%	26.77%	11.68%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31